Printer Friendly

JOHNSON & JOHNSON DIVIDES ETHICON INTO TWO SEPARATE COMPANIES

     JOHNSON & JOHNSON DIVIDES ETHICON INTO TWO SEPARATE COMPANIES
    NEW BRUNSWICK, N.J., Feb. 27 /PRNewswire -- Johnson & Johnson (NYSE: JNJ), the health care products manufacturer, has announced the division of its Ethicon, Inc. subsidiary into two separate companies.
    Company Group Chairman Frank G. Fitzpatrick said the split into two companies, Ethicon Endo-Surgery and Ethicon, Inc., "is due to newly defined opportunities in the endoscopic surgery or small incision surgery market, as well as continuing growth and challenges in the market for sutures and other products for precise wound closure."
    Fitzpatrick added:  "The reorganization also will allow us to manage the new endoscopic surgery opportunity on a worldwide basis."  He pointed out that the two organizations had been functioning as divisions within Ethicon, Inc.
    Frank J. Ryan has been named president of Ethicon, Inc., which develops and markets surgical sutures, needles, ligatures and adhesion prevention products.  Ethicon, Inc. is headquartered in Somerville, N.J.
    William C. Weldon has been named president of Ethicon Endo-Surgery, which focuses on the development and marketing of innovative endoscopic instruments for less invasive surgery. Ethicon Endo-Surgery is headquartered in Cincinnati.
    Weldon reports to Robert W. Croce, worldwide president of Ethicon Endo-Surgery and a Johnson & Johnson international vice president. Besides the United States operations of Ethicon Endo-Surgery, Croce is responsible for the company's facilities in Europe and Japan.  Croce reports to Fitzpatrick.
    Ryan joined Ethicon, Inc. in 1963 and became group vice president in 1986.  He was named president of Johnson & Johnson's Chicopee subsidiary in 1987 and subsequently became president of Johnson & Johnson Hospital Services Inc.  Ryan reports to Fitzpatrick.
    Weldon joined Johnson & Johnson's McNeil Pharmaceutical subsidiary in 1971 and later served in international positions in the Philippines; in Korea as managing director of Korea McNeil, Ltd., and in the United Kingdom as managing director of Ortho-Cilag Pharmaceutical Ltd.  Since 1989 he has been vice president of marketing and sales for the Janssen Pharmaceutica subsidiary in Piscataway, N.J.
    Ethicon Endo-Surgery helps surgeons develop new, less invasive surgical procedures and the products that help make them possible.  It has a complete line of internal and skin staplers, ligation products, and endoscopic instruments.  In 1991 the company introduced more than 45 new products for endoscopic surgery and it is planning to introduce another 60 endoscopic instruments this year.
    Ethicon, Inc. develops and markets thousands of innovative products for surgeons.  Its sutures and related products are designed to facilitate precise wound closure.  The company also provides products for the reduction of adhesions created through surgery or other clinical causes, and it also is developing pharmacology products for use during surgery.
    Johnson & Johnson, with $12.45 billion in sales, is the world's largest and most comprehensive manufacturer of health care products serving the consumer, pharmaceutical and professional markets.  It has 166 operating companies in 52 countries around the world, selling products in more than 150 countries.
    -0-                            2/28/92
    /Contact:  D. P. Swearingen of Johnson & Johnson,908-524-3538, or home, 908-389-9641; or Peter Steinerman of Ruder-Finn, 212-715-1677, or home, 516-569-0228, for Johnson & Johnson/
    (JNJ) CO:  Johnson & Johnson; Ethicon Inc. ST:  New Jersey, Ohio IN:  MTC SU:  RCN AH -- NY034 -- 3235 02/27/92 11:42 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 27, 1992
Words:525
Previous Article:SPECIALTY CHEMICAL RESOURCES OF CLEVELAND BRINGS OFFERING TO THE AMERICAN STOCK EXCHANGE
Next Article:MICROAGE TO MARKET RISC SYSTEM/6000 PRODUCTS
Topics:


Related Articles
COURT RULES FOR JOHNSON & JOHNSON ON LAPAROSCOPIC SURGERY PRODUCT
JOHNSON & JOHNSON DIVIDES ETHICON INTO TWO SEPARATE COMPANIES
ALLIANCE BETWEEN JOHNSON & JOHNSON DIVISION AND OLYMPUS OPTICAL ANNOUNCED FOR ENDOSCOPIC SURGERY
VHA SIGNS $1.2 BILLION SOLE-SOURCE AGREEMENTS FOR SUTURES, STAPLERS AND ENDOSCOPIC SURGERY PRODUCTS WITH JOHNSON & JOHNSON SUBSIDIARIES
JOHNSON & JOHNSON TO ACQUIRE MITEK SURGICAL PRODUCTS, INC. IN STOCK TRANSACTION
ETHICON'S TWO MOTIONS AGAINST UNITED STATES SURGICAL CORPORATION DENIED BY FEDERAL COURT
ETHICON ENDO-SURGERY, INC. COMPLETES INITIAL CLINICAL CASES FOR VEIN HARVESTING DURING CORONARY BYPASS
USSC Wins Third Major Lawsuit Against Ethicon
Focal, Inc. Grants Surgical Sealant Product Rights To Ethicon, Inc., a Johnson & Johnson Company
CLOSURE Medical Provides Johnson & Johnson Wound Management Exclusive Rights To Occlusive Dressing Technology, the Company's Fifth Major Product...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters